SCHEMBL21395917

SCHEMBL21395917

N#Cc1ccc(-c2ccc3c4cc(-c5cnc6c(ccc7cccnc76)c5)ccc4n(-c4ccccc4)c3c2)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 1/20 0.42
FABP1 P07148 1/20 0.38
PGR P06401 2/20 0.36
PI4KA P42356 1/20 0.36
PIK3CG P48736 1/20 0.36
CYP17A1 P05093 1/20 0.35
CYP11B1 P15538 1/20 0.35
CYP11B2 P19099 1/20 0.35
PIK3CD O00329 2/20 0.35
PIK3CA P42336 2/20 0.35
MTOR P42345 1/20 0.35
METAP2 P50579 1/20 0.35
RIPK1 Q13546 1/20 0.35
PDPK1 O15530 1/20 0.34
CCR1 P32246 1/20 0.34
CCR5 P51681 1/20 0.34
CCR8 P51685 1/20 0.34
MAPK1 P28482 1/20 0.33
GABRA1 P14867 1/20 0.33
GABRG2 P18507 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21395910 0.93 PDE4D (0.40) PARP1CYP17A1CYP11B1CYP11B2PIK3CA
SCHEMBL21395912 0.89 TRPA1 (0.41) PIK3CAMTORMETAP2CCR1CCR5
SCHEMBL21395913 0.88 FABP1 (0.38) PARP1FABP1PGRPIK3CDPIK3CA
SCHEMBL21396191 0.84 FABP1 (0.40) FABP1PGRCYP17A1CYP11B1CYP11B2
SCHEMBL21395915 0.83 FABP1 (0.38) PARP1FABP1PGRCYP11B1CYP11B2
SCHEMBL21396160 0.83 FABP1 (0.40) PARP1FABP1PGRCYP11B1CYP11B2
SCHEMBL21395839 0.82 FABP1 (0.40) FABP1CYP17A1CYP11B1CYP11B2PIK3CD
SCHEMBL21395849 0.82 CYP11B1 (0.37) FABP1CYP17A1CYP11B1CYP11B2PIK3CD
SCHEMBL21395914 0.81 PDE4D (0.40) FABP1
SCHEMBL16557714 0.80 FABP1 (0.41) FABP1PGRCYP17A1CYP11B1CYP11B2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190292169-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2019-09-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190292169-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME LAGE3, PPOX, SUN2 PARP1 1538/4885FABP1 4775/4885PGR 1369/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.